or Try an Advanced Search...

    Technical Analysis for GRAL - GRAIL, Inc.

    Grade Last Price % Change Price Change
    B 15.86 5.07% 0.77
    GRAL closed up 2.03 percent on Wednesday, November 20, 2024, on 73 percent of normal volume.
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent N/A Up Up
    Historical GRAL trend table...
    Date Alert Name Type % Chg
    50 DMA Support Bullish 7.20%
    Crossed Above 20 DMA Bullish 7.20%
    Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 7.20%
    Inside Day Range Contraction 7.20%
    Fell Below 20 DMA Bearish 13.25%
    50 DMA Support Bullish 13.25%
    Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 13.25%
    Down 3 Days in a Row Weakness 13.25%
    Upper Bollinger Band Walk Strength 7.13%
    Jack-in-the-Box Bullish Bullish Swing Setup 0.28%
    Older End-of-Day Signals for GRAL ...

       Recent Intraday Alerts

    Alert Time
    10 DMA Support 8 minutes ago
    60 Minute Opening Range Breakout about 3 hours ago
    Up 3% about 3 hours ago
    Rose Above Previous Day's High about 4 hours ago
    Up 2% about 4 hours ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Read My Charts!
    Configure default chart indicators
    GRAL Chart by TradingView
    Basic chart:

    Profile

    • Earnings date: Unknown
    Grail develops a pan-cancer screening test designed to detect cancers at an early stage. Its pan-cancer screening test measures circulating nucleic acids in blood using high-intensity sequencing, population-scale clinical trials, enabling doctors to develop blood tests for early-stage cancer detection. The company was founded in 2016 by Alex Aravanis and Jeff Huber in Menlo Park, California.
    Classification
    Sector: Healthcare
    Industry: Diagnostics & Research
    Keywords: Cancer Medical Genetics Medical Test Cancer Screening Screening Cancer Detection

    Is GRAL a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 2 bullish, 0 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Nov 19 GRAIL to Participate in Upcoming Investor Conferences
    Nov 18 GRAIL Announces First Patient Tested With Blood-Based Assay in Global Phase 3 Adjuvant Lung Cancer Study
    Nov 18 Is Illumina, Inc. (ILMN) the Best Immunotherapy Stock to Buy Now?
    Nov 15 GRAIL Inc. (GRAL) Q3 2024 Earnings Call Transcript
    Nov 14 GRAIL Inc (GRAL) Q3 2024 Earnings Call Highlights: Strong Revenue Growth Amidst Strategic ...
    Nov 14 GRAIL Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag
    Nov 12 GRAIL GAAP EPS of -$3.94, revenue of $28.65M misses by $5.25M
    Nov 12 GRAIL Reports Third Quarter 2024 Financial Results
    Nov 12 Earnings Scheduled For November 12, 2024
    Nov 4 GRAIL to Present at the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum
    See more GRAL news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 23.36
    52 Week Low 12.33
    Average Volume 652,164
    200-Day Moving Average 0.00
    50-Day Moving Average 13.90
    20-Day Moving Average 14.23
    10-Day Moving Average 15.02
    Average True Range 0.95
    RSI (14) 55.75
    ADX 17.29
    +DI 23.48
    -DI 19.12
    Chandelier Exit (Long, 3 ATRs) 13.70
    Chandelier Exit (Short, 3 ATRs) 15.61
    Upper Bollinger Bands 16.07
    Lower Bollinger Band 12.38
    Percent B (%b) 0.73
    BandWidth 25.97
    MACD Line 0.33
    MACD Signal Line 0.29
    MACD Histogram 0.0431
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 16.29
    Resistance 3 (R3) 16.29 15.88 16.09
    Resistance 2 (R2) 15.88 15.58 15.89 16.02
    Resistance 1 (R1) 15.49 15.39 15.69 15.49 15.96
    Pivot Point 15.08 15.08 15.18 15.09 15.08
    Support 1 (S1) 14.69 14.78 14.89 14.69 14.22
    Support 2 (S2) 14.28 14.59 14.29 14.16
    Support 3 (S3) 13.89 14.28 14.09
    Support 4 (S4) 13.89